Capstone Publishes Investor FAQ Detailing 72% Reduction in Convertible Principal and Reaffirming FY2026 Guidance
Go back to Capstone Publishes Investor FAQ Detailing 72% Reduction in Convertible Principal and Reaffirming FY2026 Guidance| Capstone Therapeutics Corp (NASDAQ: CAPS) | Delayed: 0.28 -0.01 (3.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.29 | 52 Week High | $0.15 | |||
| Open | $0.29 | 52 Week Low | $0.04 | |||
| Day High | $0.30 | P/E | N/A | |||
| Day Low | $0.28 | EPS | $-0.27 | |||
| Volume | 117,363 | |||||
